TAKEDA PHARMACEUTI (TKPYY)

20.90
0.17 0.82
OTC
Prev Close 20.73
Open 21.18
Day Low/High 20.87 / 21.18
52 Wk Low/High 20.55 / 31.29
Volume 224.64K
Exchange OTC
Shares Outstanding 1589.38B
Market Cap 35.15B
Div & Yield N.A. (N.A)

Latest News

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

U.S. stocks attempted to reverse the global tide Wednesday, with futures improving after better-than-expected earnings from Boeing and Twitter and a spate of multi-billion merger deals at home and abroad.

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

U.S. stock futures point to further losses for Wall Street and global stocks slump on Wednesday; Facebook, Boeing and AMD report earnings; Takeda sweetens offer for Shire.

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

As Wall Street prepares for another rough day, these are the business stories you must know.

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow fell triple digits after starting the day off in the green.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

Oil remained near a three-year high despite falling back slightly on Thursday.

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

China on Friday said it would counter Trump's proposed new tariffs 'to the end, and at any cost'

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Wall Street is also expected to start the day in positive territory on Thursday after tumultuous trading on Wednesday.

The Dow Falls Into Wednesday's Close

The Dow Falls Into Wednesday's Close

Strength in the morning yields to weakness in the afternoon session as stocks are sold off Wednesday.

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Shire Pharmaceuticals shares hit a year-to-date high Wednesday after Japan's biggest drugmaker, Takeda, confirmed it may make a takeover approach for the U.K.-listed group.

Mindstrong Health And Takeda Partner To Explore Development Of Digital Biomarkers For Mental Health Conditions

Mindstrong Health And Takeda Partner To Explore Development Of Digital Biomarkers For Mental Health Conditions

Deal combines Mindstrong's digital phenotyping platform with Takeda's development capabilities

The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. A Top Place To Work For 2017

The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. A Top Place To Work For 2017

Annual Award Spotlights Takeda's Local Workforce Talent and Commitment to Enhancing Employee Development

The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever Of The Chicago Area 2017 Top Workplaces Award

The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever Of The Chicago Area 2017 Top Workplaces Award

Takeda's Commitment to Investing in Deerfield Operations Yields Positive Employee Survey Results

The Next Target in Biotech Land

The Next Target in Biotech Land

The Actelion buyout opens the way for other deals.

The Next Target in Biotech Land

The Next Target in Biotech Land

The Actelion buyout opens the way for other deals.

4 Biotech Names That Could Be M&A Targets

4 Biotech Names That Could Be M&A Targets

Animal health and oncology deal activity is heating up in 2017.